Instructions for Authors

Comprehensive guidelines for preparing and submitting your transplant research manuscript.

• Provide sufficient detail to allow independent replication of experiments
• Identify all drugs by generic names with manufacturer information
• Describe statistical methods precisely with software version used
• Include sample size calculations and power analysis justification
• Specify equipment manufacturers with model numbers and locations
• Reference previously published methods rather than repeating

Prospective interventional clinical studies must be registered in an ICMJE-approved registry before enrollment of the first participant. Include the registration number prominently in the abstract. Report all pre-specified primary and secondary outcomes. Explain any protocol deviations or amendments that occurred during the study. Provide a CONSORT flow diagram showing participant flow through all stages of the trial.

Systematic reviews and meta-analyses should be registered prospectively in PROSPERO and follow PRISMA 2020 reporting guidelines. Include a completed PRISMA checklist as supplementary material. Submit a flow diagram showing the study identification, screening, eligibility assessment, and inclusion process with numbers at each stage. Assess risk of bias using validated tools such as Cochrane RoB 2 for randomized trials, ROBINS-I for non-randomized studies, or Newcastle-Ottawa for observational research.

• Resolution: Minimum 300 dpi for all images. Use TIFF, PNG, or high-quality JPEG formats.
• Color: RGB color mode for online publication. CMYK available on request for print applications.
• Legends: Each figure requires a standalone caption explaining all elements, abbreviations, and symbols.
• Tables: Submit as editable text not images. Include title and footnotes explaining all abbreviations.
• Microscopy: Include scale bars and magnification. State staining methods used and imaging equipment.
• Patient Images: Ensure complete anonymity. Obtain written consent for any potentially identifiable photographs.

JOT follows ICMJE authorship criteria. All listed authors must have made substantial contributions to: conception or design of the work, or acquisition, analysis, or interpretation of data; AND drafting the article or critically revising it for important intellectual content; AND final approval of the version to be published; AND agreement to be accountable for all aspects of the work. Contributors who do not meet all four criteria should be listed in the Acknowledgments section with their specific contribution described.

Use AMA American Medical Association citation style. Number references consecutively in order of first citation in text. Include DOIs when available. Verify accuracy of all citations before submission. Cite primary sources rather than review articles when possible.

• Cover letter addressed to Editor-in-Chief stating novelty and significance
• Title page with all author details, affiliations, and ORCID identifiers
• Blinded manuscript file with no author information in body text
• Structured abstract with keywords following required format
• High-resolution figures with descriptive captions as separate files
• Editable tables with titles and footnotes explaining abbreviations
• Ethics approval documentation confirming IRB or IACUC approval
• Conflict of interest declarations from all authors
• Reporting guideline checklist (CONSORT, STROBE, PRISMA as applicable)
• Data availability statement describing access to underlying research data

Upon acceptance, you will receive page proofs for review within 5-7 business days. Carefully review for typographical errors, figure quality, table formatting accuracy, and reference correctness. Return proofs within 48 hours to avoid publication delays. Only minor corrections are permitted at proof stage. Article processing charges become due at proof stage with invoices issued to corresponding author or designated institution.